MALARIA
Clinical trials for MALARIA explained in plain language.
Never miss a new study
Get alerted when new MALARIA trials appear
Sign up with your email to follow new studies for MALARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Genetically altered malaria vaccine shows promise in early human trial
⭐️ VACCINE ⭐️ OngoingThis early-stage study tests a new malaria vaccine made from weakened parasites that are designed to stop growing late in the liver, before causing blood infection. About 22 healthy adults who have never had malaria will receive the vaccine or a placebo to check for safety and im…
Matched conditions: MALARIA
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated May 06, 2026 16:02 UTC
-
New mosquito nets could slash malaria cases in High-Risk areas
Disease control OngoingThis study tests two new types of mosquito nets—Interceptor G2 and Veeralin—against standard nets to see which best prevents malaria in children aged 6 months to 10 years and adults in central Côte d'Ivoire. About 1,650 people are taking part. The goal is to find better tools to …
Matched conditions: MALARIA
Phase: NA • Sponsor: London School of Hygiene and Tropical Medicine • Aim: Disease control
Last updated May 07, 2026 18:41 UTC
-
New malaria drug tested in infants could boost vaccine power
Prevention OngoingThis study tests a new medicine called L9LS to prevent malaria in infants aged 1 to 12 months in Mali. Researchers want to see if it is safe and how it works in the body, and also if it affects a malaria vaccine given later. About 180 healthy infants will take part, and the study…
Matched conditions: MALARIA
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated May 04, 2026 16:21 UTC
-
Malaria vaccine study canceled before it began
Knowledge-focused TerminatedThis study was designed to test whether giving a monoclonal antibody (L9LS) before the R21/Matrix-M malaria vaccine changes how well the vaccine works. It planned to enroll healthy adults and infants in Mali. However, the study was withdrawn before any participants were enrolled,…
Matched conditions: MALARIA
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 08, 2026 12:04 UTC